Eliem Therapeutics, Inc. (ELYM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 10:23AM EDT. Market open.
| Previous Close | 10.20 |
| Open | 10.27 |
| Bid | 10.28 x 200 |
| Ask | 10.74 x 200 |
| Day's Range | 9.90 - 10.75 |
| 52 Week Range | 2.34 - 11.55 |
| Volume | |
| Avg. Volume | 873,250 |
| Market Cap | 291.516M |
| Beta (5Y Monthly) | 0.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
Eliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Zacks
Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%
Eliem (ELYM) announces its decision to halt its Kv7 development program in its quest to explore strategic alternatives. The stock of the company rises 6% in response on Thursday.
© 2024 Yahoo. All rights reserved.